• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Liver injury in COVID-19: management and challenges.

作者信息

Zhang Chao, Shi Lei, Wang Fu-Sheng

机构信息

Treatment and Research Center for Infectious Diseases, The Fifth Medical Center of PLA General Hospital, National Clinical Research Center for Infectious Diseases, Beijing 100039, China.

Treatment and Research Center for Infectious Diseases, The Fifth Medical Center of PLA General Hospital, National Clinical Research Center for Infectious Diseases, Beijing 100039, China.

出版信息

Lancet Gastroenterol Hepatol. 2020 May;5(5):428-430. doi: 10.1016/S2468-1253(20)30057-1. Epub 2020 Mar 4.

DOI:10.1016/S2468-1253(20)30057-1
PMID:32145190
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7129165/
Abstract
摘要

相似文献

1
Liver injury in COVID-19: management and challenges.新型冠状病毒肺炎中的肝损伤：管理与挑战
Lancet Gastroenterol Hepatol. 2020 May;5(5):428-430. doi: 10.1016/S2468-1253(20)30057-1. Epub 2020 Mar 4.
2
Management of liver diseases during the pandemic of coronavirus disease-19.2019冠状病毒病大流行期间的肝病管理
Clin Mol Hepatol. 2020 Jul;26(3):243-250. doi: 10.3350/cmh.2020.0111. Epub 2020 Jun 23.
3
Pandemic Pandemonium: Pausing Clinical Research During the COVID-19 Outbreak.大流行的混乱：在新冠疫情期间暂停临床研究
Circulation. 2020 Jun 23;141(25):2045-2047. doi: 10.1161/CIRCULATIONAHA.120.047347. Epub 2020 Apr 22.
4
New York City Innocence Lost: Cardiology in the COVID-19 Pandemic.纽约市的无辜者蒙冤：新冠疫情中的心脏病学
Circulation. 2020 Jun 23;141(25):2039-2041. doi: 10.1161/CIRCULATIONAHA.120.047265. Epub 2020 Apr 7.
5
The COVID-19 Pandemic: A Global Natural Experiment.新冠疫情：一项全球自然实验。
Circulation. 2020 Jul 7;142(1):14-16. doi: 10.1161/CIRCULATIONAHA.120.047538. Epub 2020 Apr 23.
6
Establishment and Management of Mechanical Circulatory Support During the COVID-19 Pandemic.新型冠状病毒肺炎大流行期间机械循环支持的建立与管理
Circulation. 2020 Jul 7;142(1):10-13. doi: 10.1161/CIRCULATIONAHA.120.047415. Epub 2020 May 4.
7
COVID-19 Leads to Major Changes for Cardiologists in Training.新冠疫情给心血管内科住院医师带来重大改变。
Circulation. 2020 Jul 14;142(2):175-177. doi: 10.1161/CIRCULATIONAHA.120.049256. Epub 2020 Jul 13.
8
[Not Available].[不可用]。
Rev Med Suisse. 2020 May 6;16(692):930-932.
9
International Expansion of a Novel SARS-CoV-2 Mutant.一种新型严重急性呼吸综合征冠状病毒2（SARS-CoV-2）突变株的国际传播
J Virol. 2020 Jun 1;94(12). doi: 10.1128/JVI.00567-20.
10
International perspectives: Impact of the COVID-19 pandemic on cytology.国际视角：新冠疫情对细胞学的影响
Cancer Cytopathol. 2020 May;128(5):307-308. doi: 10.1002/cncy.22275. Epub 2020 Apr 7.

引用本文的文献

1
Breathless Aftermath: Post-COVID-19 Pulmonary Fibrosis.气喘吁吁的后果：新冠后肺纤维化
Viruses. 2025 Aug 9;17(8):1098. doi: 10.3390/v17081098.
2
The Impact of COVID-19 and COVID-19 Vaccination on Detection, Assessment, and Management of Suspected Acute Drug-Induced Liver Injury Occurring during Clinical Trials: Consensus Recommendations from the IQ DILI Initiative.2019年冠状病毒病（COVID-19）及COVID-19疫苗接种对临床试验期间疑似急性药物性肝损伤的检测、评估及管理的影响：IQ药物性肝损伤倡议组织的共识建议
Drug Saf. 2025 Aug 5. doi: 10.1007/s40264-025-01591-0.
3
Outcomes of SARS-CoV-2 infection in patients under treatment with pharmacological immunosuppression. A Swiss cohort study.接受药物免疫抑制治疗患者的新冠病毒感染结局。一项瑞士队列研究。
Arch Med Sci. 2022 Aug 3;21(3):845-851. doi: 10.5114/aoms/152340. eCollection 2025.
4
Hematological Parameter-Derived Inflammatory Scores in Non-Pancreatic Hyperlipasemia (NPHL)-The Prognosis Lies in the Blood.非胰腺性高胰脂肪酶血症（NPHL）中基于血液学参数的炎症评分——预后取决于血液。
Biomedicines. 2025 Jul 14;13(7):1719. doi: 10.3390/biomedicines13071719.
5
Liver injury in post-acute COVID-19 syndrome: A systematic review and meta-analysis of early observational studies.急性后新冠综合征中的肝损伤：早期观察性研究的系统评价和荟萃分析
Can Liver J. 2024 Dec 19;7(4):470-489. doi: 10.3138/canlivj-2024-0010. eCollection 2024 Dec.
6
COVID-19 Induced Cholangiopathy: A Case Report.新型冠状病毒肺炎诱发的胆管病：一例报告
Case Rep Gastroenterol. 2025 Jul 16;19(1):519-526. doi: 10.1159/000546723. eCollection 2025 Jan-Dec.
7
Epidemiology of COVID-19: Implications for a Gastroenterologist.新型冠状病毒肺炎的流行病学：对胃肠病学家的启示
J Dig Endosc. 2020 Mar;11(1):8-12. doi: 10.1055/s-0040-1712549. Epub 2020 May 16.
8
Hepatobiliary and Pancreatic Manifestations of Coronavirus Disease 2019.2019冠状病毒病的肝胆胰表现
J Dig Endosc. 2020 Mar;11(1):21-23. doi: 10.1055/s-0040-1712079. Epub 2020 May 16.
9
COVID-19 and Liver Injury, Beyond the First Pandemic Waves: Clinical and Immune-Virological Features.新冠疫情第一波高峰之后的COVID-19与肝损伤：临床及免疫病毒学特征
J Viral Hepat. 2025 Jul;32(7):e70039. doi: 10.1111/jvh.70039.
10
Coronavirus disease 2019-associated liver injury in pregnancy: A case report.2019年冠状病毒病合并妊娠肝损伤：一例报告
J Int Med Res. 2025 May;53(5):3000605251344150. doi: 10.1177/03000605251344150. Epub 2025 May 28.

本文引用的文献

1
Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study.中国武汉 81 例新冠肺炎患者的放射学特征：一项描述性研究。
Lancet Infect Dis. 2020 Apr;20(4):425-434. doi: 10.1016/S1473-3099(20)30086-4. Epub 2020 Feb 24.
2
Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study.中国武汉严重 COVID-19 患者的临床病程和结局：一项单中心、回顾性、观察性研究。
Lancet Respir Med. 2020 May;8(5):475-481. doi: 10.1016/S2213-2600(20)30079-5. Epub 2020 Feb 24.
3
Enteric involvement of coronaviruses: is faecal-oral transmission of SARS-CoV-2 possible?冠状病毒的肠道感染：严重急性呼吸综合征冠状病毒2（SARS-CoV-2）通过粪口途径传播是否可能？
Lancet Gastroenterol Hepatol. 2020 Apr;5(4):335-337. doi: 10.1016/S2468-1253(20)30048-0. Epub 2020 Feb 20.
4
Pathological findings of COVID-19 associated with acute respiratory distress syndrome.与急性呼吸窘迫综合征相关的新型冠状病毒肺炎的病理表现
Lancet Respir Med. 2020 Apr;8(4):420-422. doi: 10.1016/S2213-2600(20)30076-X. Epub 2020 Feb 18.
5
Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series.一组在中国武汉以外地区感染 2019 年新型冠状病毒（SARS-CoV-2）的患者的临床特征：回顾性病例系列。
BMJ. 2020 Feb 19;368:m606. doi: 10.1136/bmj.m606.
6
What to do next to control the 2019-nCoV epidemic?接下来要采取什么措施来控制2019新型冠状病毒疫情？
Lancet. 2020 Feb 8;395(10222):391-393. doi: 10.1016/S0140-6736(20)30300-7.
7
Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China.《武汉 2019 年新型冠状病毒感染的肺炎 138 例住院患者临床特征分析》
JAMA. 2020 Mar 17;323(11):1061-1069. doi: 10.1001/jama.2020.1585.
8
Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study.中国武汉 99 例 2019 年新型冠状病毒肺炎患者的流行病学和临床特征：描述性研究。
Lancet. 2020 Feb 15;395(10223):507-513. doi: 10.1016/S0140-6736(20)30211-7. Epub 2020 Jan 30.
9
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.中国武汉地区 2019 年新型冠状病毒感染患者的临床特征。
Lancet. 2020 Feb 15;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5. Epub 2020 Jan 24.
10
Histopathology of Middle East respiratory syndrome coronovirus (MERS-CoV) infection - clinicopathological and ultrastructural study.中东呼吸综合征冠状病毒（MERS-CoV）感染的组织病理学 - 临床病理和超微结构研究。
Histopathology. 2018 Feb;72(3):516-524. doi: 10.1111/his.13379. Epub 2017 Nov 21.